Bio-Rad Reports Third-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Bio-Rad Labs (BIO) Tops Q3 EPS by $1.20
October 29, 2020 4:20 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $3.00, $1.20 better than the analyst estimate of $1.80. Revenue for the quarter came in at $647.3 million versus the consensus estimate of $570.58 million.
2020 Financial Outlook:
The company currently believes that full-year 2020 year-over-year currency-neutral sales... More



